跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OxyContin Neo - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
OxyContin Neo
Approved
STANDARD
OxyContin Neo
Purdue Pharmaceuticals L.P.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a0b2a0ca6994db06
Company
Purdue Pharmaceuticals L.P.
Type
Standard
Approval Details
Approval Id
a0b2a0ca6994db06
Drug Approval Philippines Name
OxyContin Neo
Product Name
OxyContin Neo
Registration Number
DR-XY45706
Brand Name
OxyContin Neo
Generic Name
Oxycodone hydrochloride
Dosage Form
Controlled-Release Tablet
Dosage Strength
20mg
Manufacturer
Purdue Pharmaceuticals L.P.
Importer
Mundipharma Distribution GmBH (Philippine Branch)
Company Detail Path
/organization/purdue-pharmaceuticals-l-p
Issuance Date
10 January 2022
Expiry Date
15 December 2026
Pharmacologic Category
Opioid Analgesic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a0b2a0ca6994db06
Type
Standard
Back to Philippines FDA Approvals